Bio-Rad Laboratories, Inc. (BIO.B) vs Glaukos Corporation (GKOS)
Bio-Rad Laboratories, Inc. and Glaukos Corporation are both Medical Devices companies. Bio-Rad Laboratories, Inc. is the larger, with a market value of $10.3B against $9.1B — 1.1× the size. Glaukos Corporation has negative trailing earnings, so its P/E is not meaningful; Bio-Rad Laboratories, Inc. trades at 43.8×. Glaukos Corporation grew revenue faster over the last twelve months: 41.6% against 1.37%. Bio-Rad Laboratories, Inc. has the higher net margin (8.59% vs −30.7%) and the higher return on invested capital (0.49% vs −26.1%). Across the 19 metrics below, Bio-Rad Laboratories, Inc. leads on 13 and Glaukos Corporation on 6.
Valuation
Profitability
| Metric | BIO.B | GKOS | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.90% | 79.12% | 56.01% |
| Operating margin | 2.05% | (31.55%) | (15.03%) |
| Net margin | 8.59% | (30.68%) | (20.40%) |
| Free cash flow margin | 13.64% | (1.99%) | (7.24%) |
| Return on equity | 3.11% | (25.98%) | (15.32%) |
| Return on assets | 2.17% | (19.72%) | (19.72%) |
| Return on invested capital | 0.49% | (26.07%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack